361 related articles for article (PubMed ID: 10383161)
21. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
22. Effects of simian virus 40 T-antigens on normal human mammary epithelial cells reveal evidence for spontaneous alterations in addition to loss of p16(INK4a) expression.
Huschtscha LI; Neumann AA; Noble JR; Reddel RR
Exp Cell Res; 2001 Apr; 265(1):125-34. PubMed ID: 11281650
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
Wang Y; Becker D
Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock.
Munro J; Barr NI; Ireland H; Morrison V; Parkinson EK
Exp Cell Res; 2004 May; 295(2):525-38. PubMed ID: 15093749
[TBL] [Abstract][Full Text] [Related]
25. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.
Kiyono T; Foster SA; Koop JI; McDougall JK; Galloway DA; Klingelhutz AJ
Nature; 1998 Nov; 396(6706):84-8. PubMed ID: 9817205
[TBL] [Abstract][Full Text] [Related]
26. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.
Kinoshita I; Dosaka-Akita H; Mishina T; Akie K; Nishi M; Hiroumi H; Hommura F; Kawakami Y
Cancer Res; 1996 Dec; 56(24):5557-62. PubMed ID: 8971152
[TBL] [Abstract][Full Text] [Related]
27. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
Chatterjee SJ; George B; Goebell PJ; Alavi-Tafreshi M; Shi SR; Fung YK; Jones PA; Cordon-Cardo C; Datar RH; Cote RJ
J Pathol; 2004 Jul; 203(3):762-70. PubMed ID: 15221935
[TBL] [Abstract][Full Text] [Related]
28. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone.
Yamamoto A; Kumakura S; Uchida M; Barrett JC; Tsutsui T
Int J Cancer; 2003 Sep; 106(3):301-9. PubMed ID: 12845665
[TBL] [Abstract][Full Text] [Related]
29. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
30. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
Geradts J; Ingram CD
Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
[TBL] [Abstract][Full Text] [Related]
31. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function.
Morris M; Hepburn P; Wynford-Thomas D
Oncogene; 2002 Jun; 21(27):4277-88. PubMed ID: 12082615
[TBL] [Abstract][Full Text] [Related]
32. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase.
Morales CP; Holt SE; Ouellette M; Kaur KJ; Yan Y; Wilson KS; White MA; Wright WE; Shay JW
Nat Genet; 1999 Jan; 21(1):115-8. PubMed ID: 9916803
[TBL] [Abstract][Full Text] [Related]
33. p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways.
Steiner MS; Wang Y; Zhang Y; Zhang X; Lu Y
Oncogene; 2000 Mar; 19(10):1297-306. PubMed ID: 10713671
[TBL] [Abstract][Full Text] [Related]
34. Expression of the HPV E7 oncoprotein mimics but does not evoke a p53-dependent cellular DNA damage response pathway.
Jones DL; Thompson DA; Suh-Bürgmann E; Grace M; Münger K
Virology; 1999 Jun; 258(2):406-14. PubMed ID: 10366578
[TBL] [Abstract][Full Text] [Related]
35. Association of p16(INK4a) and pRb inactivation with immortalization of human cells.
Tsutsui T; Kumakura S; Yamamoto A; Kanai H; Tamura Y; Kato T; Anpo M; Tahara H; Barrett JC
Carcinogenesis; 2002 Dec; 23(12):2111-7. PubMed ID: 12507935
[TBL] [Abstract][Full Text] [Related]
36. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
37. p53-Independent tumorigenic progression of human prostate cells.
Ramsamooj P; Kuettel M; Dritschilo A; Jung M
Radiat Oncol Investig; 1997; 5(6):269-74. PubMed ID: 9436243
[TBL] [Abstract][Full Text] [Related]
38. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
Lu DW; El-Mofty SK; Wang HL
Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
[TBL] [Abstract][Full Text] [Related]
39. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.
Schutte M; Hruban RH; Geradts J; Maynard R; Hilgers W; Rabindran SK; Moskaluk CA; Hahn SA; Schwarte-Waldhoff I; Schmiegel W; Baylin SB; Kern SE; Herman JG
Cancer Res; 1997 Aug; 57(15):3126-30. PubMed ID: 9242437
[TBL] [Abstract][Full Text] [Related]
40. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
McCabe MT; Davis JN; Day ML
Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
